SEC Form 4 · accession 0001401225-15-000003
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Baljinder Bhullar
Officer — CFO · Director
Period of report
Sep 21, 2015
Accepted (ET)
Sep 23, 2015 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 141,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.25 | Sep 21, 2015 | E | 100,000 | D | Mar 21, 2014 | Sep 21, 2015 | Common Shares | 100,000 | 0 | D |
| Stock Options | $0.35 | holding | — | — | — | Jul 11, 2011 | Jul 11, 2016 | Common Shares | 100,000 | 100,000 | D |
| Stock Options | $0.10 | holding | — | — | — | Jun 18, 2013 | Jun 18, 2018 | Common Shares | 175,000 | 275,000 | D |
| Stock Options | $0.11 | holding | — | — | — | Dec 23, 2014 | Dec 23, 2019 | Common Shares | 500,000 | 775,000 | D |